Detecting Fluconazole Resistance in Candida parapsilosis
Author Information
Author(s): Karthika Kanagasabapathi, Premamalini Thayanidhi, Vijayakishore Thanneru, Kindo Anupama Jyoti
Primary Institution: Sri Ramachandra Medical College & Research Institute, SRIHER, Chennai, India
Hypothesis
This study aimed to detect fluconazole resistance by targeting the Y132F mutation in the ERG11 gene in Candida parapsilosis.
Conclusion
The developed PCR assay successfully detected the Y132F mutation, allowing for early identification of fluconazole-resistant Candida parapsilosis isolates.
Supporting Evidence
- 24% of candidemia cases were caused by Candida parapsilosis.
- Fluconazole resistance was found in 16.7% of C. parapsilosis isolates.
- The PCR assay identified all fluconazole-resistant isolates with the Y132F mutation.
- The assay can detect the mutation within 3 hours.
Takeaway
Researchers created a test to quickly find out if a type of fungus called Candida parapsilosis is resistant to a medicine called fluconazole, which helps treat infections.
Methodology
The study involved collecting 75 Candida isolates from candidemia patients and using PCR to detect the Y132F mutation in the ERG11 gene.
Limitations
The study was limited to a single center and focused on one specific mutation related to fluconazole resistance.
Participant Demographics
Candidemia patients from a tertiary care center in India.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website